These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10472461)

  • 21. [Immunohistochemical study of the epithelial hyperproliferation in middle ear cholesteatoma].
    Li H; Jiang P; Wang L
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2002 Apr; 37(2):118-20. PubMed ID: 12768722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesteatoma epithelium is characterized by increased expression of Ki-67, p53 and p21, with minimal apoptosis.
    Huisman MA; De Heer E; Grote JJ
    Acta Otolaryngol; 2003 Apr; 123(3):377-82. PubMed ID: 12737294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Localisation of basic fibroblast growth factor in cholesteatoma matrix: an immunochemical study.
    Hamed MA; Sayed RH; Shiogama K; Eltaher MA; Suzuki K; Nakata S
    J Laryngol Otol; 2019 Mar; 133(3):183-186. PubMed ID: 30808433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A study on epidermal proliferation ability in cholesteatoma.
    Tanaka Y; Shiwa M; Kojima H; Miyazaki H; Kamide Y; Moriyama H
    Laryngoscope; 1998 Apr; 108(4 Pt 1):537-42. PubMed ID: 9546266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical investigations on external auditory canal cholesteatomas.
    Adamczyk M; Sudhoff H; Jahnke K
    Otol Neurotol; 2003 Sep; 24(5):705-8. PubMed ID: 14501442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of S100A1 in external auditory canal cholesteatoma.
    Naim R; Hormann K
    Oncol Rep; 2006 Oct; 16(4):671-5. PubMed ID: 16969478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 Expression and keratinocyte hyperproliferation in middle ear cholesteatoma.
    Motamed M; Powe D; Kendall C; Birchall JP; Banerjee AR
    Clin Otolaryngol Allied Sci; 2002 Dec; 27(6):505-8. PubMed ID: 12472520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of Langerhans cells, Ki-67 protein and apoptosis in acquired cholesteatoma: prospective clinical study.
    Akdogan V; Yilmaz I; Canpolat T; Ozluoglu LN
    J Laryngol Otol; 2013 Mar; 127(3):252-9. PubMed ID: 23331470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanocyte localization and distribution in human cholesteatoma.
    Olszewska E; Wagner M; Goon P; Shamaa A; Upile T; Rogowski M; Steinstaesser L; Sudhoff HH
    Histol Histopathol; 2008 Mar; 23(3):291-6. PubMed ID: 18072086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of matrix metalloproteinase 1 in cholesteatoma and deep meatal skin.
    Banerjee AR; Jones JL; Birchall JP; Powe DG
    Otol Neurotol; 2001 Sep; 22(5):579-81. PubMed ID: 11568661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Middle ear cholesteatoma: present-day concepts of etiology and pathogenesis].
    Lesinskas E; Kasinskas R; Vainutiene V
    Medicina (Kaunas); 2002; 38(11):1066-71; quiz 1141. PubMed ID: 12532718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of cytokeratins 13 and 16 in middle ear cholesteatoma.
    Sasaki H; Huang CC
    Otolaryngol Head Neck Surg; 1994 Mar; 110(3):310-7. PubMed ID: 7510866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67.
    Bujia J; Holly A; Sudhoff H; Antoli-Candela F; Tapia MG; Kastenbauer E
    ORL J Otorhinolaryngol Relat Spec; 1996; 58(1):23-6. PubMed ID: 8718533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
    Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
    Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alteration of epidermal differentiation in middle ear cholesteatoma.
    Stammberger M; Bujía J; Kastenbauer E
    Am J Otol; 1995 Jul; 16(4):527-31. PubMed ID: 8588655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Markers of epidermal proliferation in middle ear cholesteatoma].
    Hassmann-Poznańska E; Skotnicka B; Dziecioł J
    Otolaryngol Pol; 2003; 57(4):505-11. PubMed ID: 14587387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of the activity of MMP2 and MMP9 in middle ear cholesteatoma].
    Wang H; Xu Z; Tang A; Su J
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Oct; 18(10):620-2. PubMed ID: 15620146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [DNA character of the cholesteatoma].
    Cui Y; Pan H; Gao Q
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Feb; 15(2):62-3. PubMed ID: 12541864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basement membrane in middle ear cholesteatoma. Immunohistochemical and ultrastructural observations.
    Sudhoff H; Bujía J; Borkowshi G; Koc C; Holly A; Hildmann H; Fisseler-Eckhoff A
    Ann Otol Rhinol Laryngol; 1996 Oct; 105(10):804-10. PubMed ID: 8865776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Micronucleus frequency in acquired middle ear cholesteatoma.
    Oztürk K; Yildirim MS; Acar H; Arikoğlu H; Arbağ H; Ozer B
    Acta Otolaryngol; 2004 Oct; 124(8):924-8. PubMed ID: 15513528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.